Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Pesqui. vet. bras ; 37(6): 650-656, jun. 2017. tab, ilus
Article in English | LILACS, VETINDEX | ID: biblio-895460

ABSTRACT

Flaxseed is considered a functional food with several health benefits. However, because of its high phytoestrogen content, flaxseed influences hormone metabolism and affects the gonadal biomorphology. In this study, computerized histomorphometry was used to evaluate seminiferous and epididymal tubules, considering the different regions of the epididymis (head, body and tail) of rats subjected to a prolonged diet of flaxseed. Young adult male Wistar rats (n=20) were divided into 2 groups during their lactation period: Control Group (CG), fed casein-based meals and Flaxseed Group (FG), fed a 25% flaxseed meal. After 250 days of continuous ingestion, the animals were euthanized and a blood sample was collected. The testicles and epididymis were removed and fixed in buffered formalin solution. The samples were subjected to routine histological paraffin techniques and stained with hematoxilin and eosin. Immunostaining was performed using an antivimentin antibody for Sertoli cell identification. For morphometry, images of the slides were scanned and analyzed using Image J to determine the epithelial height, tubular and luminal diameter and tubular and luminal area. In the hormonal evaluation, FG had a higher serum concentration of estrogen (P=0.001), but no change was observed in the concentration of testosterone. The morphometric assay of seminiferous tubules and epididymal regions revealed no significant differences between the analyzed groups. Similarly, Sertoli cell quantification showed no significant differences in the FG (P=0.98). These results revealed that the continuous and prolonged intake of 25% flaxseed meals from gestation to 250 days of age, even with a significant increase in serum levels of estradiol, does not exert adverse effects on the testicular and epididymal structure or on the cells participating in the spermatogenesis of rats.(AU)


A semente de linhaça é considerada um alimento funcional com vários efeitos benéficos à saúde. Entretanto, devido ao seu elevado teor de fitoestrógenos, esta semente pode influenciar no metabolismo hormonal e interferir na biomorfologia gonadal. Neste estudo, utilizamos a histomorfometria computadorizada para avaliar os túbulos seminíferos e epididimários, considerando as diferentes regiões do epidídimo (cabeça, corpo e cauda) de ratos submetidos a uma dieta prolongada de semente de linhaça. Foram utilizados ratos Wistar machos adultos jovens (n=20) divididos em 2 grupos, durante o período de lactação: Grupo Controle (GC) a base de caseína e Grupo Linhaça (GL) alimentados com 25% de semente de linhaça. Ao final de 250 dias de ingestão contínua, os animais foram sacrificados e amostra de sangue foi coletada. Os testículos e epidídimos foram retirados e fixados em formol tamponado. As amostras foram submetidas ao processamento histológico de rotina para parafina e coradas em hematoxilina e eosina. Foi feita a imunomarcação com anticorpo antivimentina para identificação das células de Sertoli. Para morfometria, as imagens das lâminas foram digitalizadas e analisadas pelo software ImageJ para obtenção dos dados de altura epitelial, diâmetro e área tubular e luminal. Na avaliação hormonal o GL teve maior concentração de estrógeno sérico (p=0,001), mas nenhuma mudança na concentração de testosterona foi observada. Nos parâmetros morfométricos dos túbulos seminíferos e das regiões epididimárias, não houve diferenças significativas entre os grupos analisados. Da mesma forma, a quantificação das células de Sertoli não apresentaram diferenças significativas no GL (p=0,98). Estes resultados mostraram que o consumo contínuo e prolongado de 25% de semente de linhaça desde período gestacional até 250 dias de idade, mesmo com o aumento significativo nos níveis séricos de estradiol, não exerceram efeitos adversos sobre a estrutura testicular e epididimária, assim como nas células participantes da espermatogênese em ratos.(AU)


Subject(s)
Animals , Male , Rats , Seeds , Testis/anatomy & histology , Rats, Wistar/anatomy & histology , Flax/adverse effects , Epididymis/anatomy & histology , Seminiferous Tubules/anatomy & histology , Sertoli Cells , Vimentin , Histological Techniques/veterinary , Phytoestrogens/adverse effects
2.
Article in English | IMSEAR | ID: sea-157118

ABSTRACT

This group has advocated a return to the notional Palæolithic diet with fruits, vegetables, roots, leaves, seeds, phytochemical antioxidants and proteins, etc. Phytoestrogens, viz. lignans, isoflavonoids and flavonoids are weak oestrogenic constituents of such a diet and may have a considerable impact on human health and disease. The aim of this paper was to conduct a preliminary overview of about 2000 research-led studies from the 1930s to the present time reported in the literature on flavonoids/isoflavonoids/lignans and to assemble evidence for a future strictly formal literature review on the health benefits and risks of flavonoids in a variety of diseases.


Subject(s)
Diet, Paleolithic , Epigenesis, Genetic/physiology , Female , Growth/drug effects , Humans , Maternal-Fetal Exchange/drug effects , Maternal-Fetal Exchange/physiology , Phytoestrogens/adverse effects , Phytoestrogens/metabolism , Pregnancy , Sex Determination Processes/drug effects , Sex Factors
3.
Rev. chil. radiol ; 14(3): 113-121, 2008.
Article in Spanish | LILACS | ID: lil-517440

ABSTRACT

The use of Hormone Replacement Therapy (HRT) has evolved from a massive utilization to a restricted use under very precise medical indications, in the light of the deletereous effects its indiscriminate prescription could entail. It is not beneficial for secondary prevention, but rather implies additional cardiocerebrovascular risks, and therefore it must be preferentially employed during perimenopausic and non-late periods, in the smallest possible dose and only over short periods of time, restricting its prescription to women presenting with severe estrogen deprivation syndrome or to osteoporotic patients intolerant to calcium and bifosfonates therapy. Breast cancer risk -which is low- is related to a estrogen therapy extended for more than seven years or associated with the use of progesterone for a period exceeding five years. Personal medical records of breast cancer imply absolute contraindication. Currently there are no research work supporting the safe use of phytoestrogens as an alternative therapy. It is likely that in upcoming days transdermal estrogen administration associated with natural progesterone could allow an increased use of them, but for the time being there are no massive studies supporting their recommendation.


El uso de terapia de reemplazo hormonal ha evolucionado desde su empleo masivo a un uso restringido bajo indicaciones precisas, a la luz de los efectos deletéreos que pudiera significar su indicación indiscriminada. No es de utilidad en la prevención secundaria y más bien representa riesgos adicionales cardiovasculares y cerebro vasculares, por lo que se debe emplear de preferencia en el periodo peri-menopáusico y no tardío, en la menor dosis posible y por el menor tiempo necesario, restringiendo su indicación a las mujeres con síntomas de deprivación estrogénica severa o a mujeres osteoporóticas que no toleran la terapia de calcio y bifosfonatos. El riesgo de cáncer de mama -que es bajo- está relacionado con una terapia estrogénica prolongada de 7 años o más o en asociación con el empleo de progesterona por más de 5 años. Antecedentes personales de cáncer de mama representan una contraindicación absoluta. No hay trabajos a la fecha que apoyen el empleo sin riesgo de fitoestrógenos como una terapia alternativa al uso de estrógenos. Es posible que en el futuro la administración transdérmica de los estrógenos, asociado a progesteronas naturales permitan su mayor utilización, pero aún no se dispone de estudios masivos que aprueben su recomendación.


Subject(s)
Humans , Female , Phytoestrogens/administration & dosage , Breast Neoplasms/chemically induced , Hormone Replacement Therapy/adverse effects , Phytoestrogens/adverse effects , Menopause , Breast Neoplasms/prevention & control
4.
Article in English | IMSEAR | ID: sea-39185

ABSTRACT

OBJECTIVE: To evaluate the preliminary efficacy and safety of Pueraria mirifica (Kwao Keur Kao), phytoestrogen, for the alleviation of climacteric symptoms. MATERIAL AND METHOD: Perimenopausal women attending with climacteric symptoms, such as hot flushes and night sweats, were invited to join the present study, conducted at the Menopausal Clinic, Hat Yai Regional Hospital. The patients were voluntarily enrolled and randomly received the raw material of Pueraria mirifica, oral 50 and 100 mg capsule, once daily for six months, as an open-label study. RESULTS: Of the 10 enrolled patients, 8 cases were completely evaluated. The modified Greene climacteric scale (MGCS) was satisfactorily decreased in both groups. The average scale declined from 44.1 at baseline, to be 26, 17, and 11.1 at 1-, 3-, and 6- month follow-up respectively. No other laboratory abnormalities, except one case had transiently increased the creatinine level, and one case of increased blood urea nitrogen. The mean serum estradiol was slightly increased, while the mean serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were nearly stable. CONCLUSION: Pueraria mirifica is relatively safe and preliminarily alleviates the climacteric symptoms in perimenopausal. women, but the data is insufficient to draw definite conclusions regarding the estrogenic effect.


Subject(s)
Adult , Climacteric , Clinical Trials as Topic/methods , Estrogens/pharmacology , Female , Female Urogenital Diseases/drug therapy , Herbal Medicine , Humans , Isoflavones/therapeutic use , Menopause/drug effects , Middle Aged , Phytoestrogens/adverse effects , Phytotherapy , Pueraria/adverse effects , Thailand
5.
Arq. bras. endocrinol. metab ; 51(3): 500-503, abr. 2007. tab
Article in Portuguese | LILACS | ID: lil-452194

ABSTRACT

Telarca precoce, desenvolvimento mamário antes dos 8 anos de idade, apresenta dois picos de incidência, nos dois primeiros anos de vida e após os 6 anos de idade. Uma menina de 4,75 anos apresentou-se com telarca associada à ingestão excessiva de fitoestrógenos. O desenvolvimento puberal M2P1-2, os níveis hormonais e o US pélvico eram compatíveis com puberdade precoce periférica. Durante o seguimento, observou-se ingestão diária de alimentos baseados em soja (> 40 mg fitoestrógenos/dia). Soja contém fitoestrógenos, principalmente genisteína e daidzeína. Embora menos potentes do que o estradiol, sua concentração pode ser 13.000 a 22.000 vezes maior em crianças alimentadas somente com fórmulas baseadas em soja. Os pais foram aconselhados a reduzir para uma vez na semana o seu fornecimento na dieta. O desenvolvimento puberal cessou em M2-3P1 e a paciente, com 8,66 anos, continua a desenvolver-se com idades óssea e cronológica equivalentes. Questões relacionadas à segurança alimentar, principalmente de alimentos baseados em soja, permanecem sem respostas precisas. Embora sejam conhecidas as etiologias da puberdade precoce não progressiva e da telarca prematura, neste caso esteve fortemente relacionada à ingestão excessiva de soja e de outros alimentos ricos em fitoestrógenos que poderiam ter desencadeado a telarca atuando como desreguladores endócrinos.


Precocious thelarche is the breast development before 8 years of age with two peaks of incidence during the first two years of life and after 6 years of age. A 4.75-year-old girl presented with thelarche associated to an excessive intake of phytoestrogens (phye). Tanner development B2P1-2, hormonal levels and pelvic US were compatible with peripheral precocious puberty. During follow-up, a daily intake of soy-based foods was observed (> 40 mg phye/day). Soy is rich in phytoestrogens, mainly genistein and daidzein. Although phye are less strong than estradiol, its concentration could be from 13,000 to 22,000 times stronger in children fed only by soy-based formulas. Parents were advised and soy intake was reduced to once a week. Progression of pubertal development ceased at B2-3P1. The patient, now 8.66 years old, keeps growing with similar bone and chronological ages. Some questions related to industrial food security, mainly the soy-based food, remain without precise answer. Although it is well known the entity of non-progressive precocious puberty and premature thelarche, pubertal development in this case was strongly related to excessive daily intake of soy and other phye-rich food that could trigger puberty as endocrine disruptor.


Subject(s)
Child, Preschool , Female , Humans , Breast/growth & development , Phytoestrogens/adverse effects , Puberty, Precocious/chemically induced , Soy Foods/adverse effects , Breast/drug effects , Endocrine Disruptors/adverse effects , Phytoestrogens/administration & dosage , Glycine max
6.
Rev. invest. clín ; 59(1): 73-81, ene.-feb. 2007. ilus, tab
Article in Spanish | LILACS | ID: lil-632393

ABSTRACT

Different perturbations during fetal and post natal development unleash endocrine adaptations that permanently alter metabolism, increasing the susceptibility to develop later disease, process known as "developmental programming"'. Endocrine disruptor compounds (EDC) are widely spread on the environment and display estrogenic, anti-estrogenic or anti-androgenic activity; they are lypophilyc and stored for long periods on the adipose tissue. Maternal exposure to EDC during pregnancy and lactation produces the exposure of the fetus and neonate through placenta and breast milk. Epidemiological and experimental studies have demonstrated reproductive alterations as a consequence of intrauterine and/or neonatal exposure to EDC. Diethystilbestrol (DES) is the best documented compound, this synthetic estrogen was administered to pregnant women at the BO and 60 to prevent miscarriage. It was implicated in urogenital abnormalities in children exposed in utero and withdrawn from the market. The "DES daughters" are women with high incidence of vaginal hypoplasia, spontaneous abortion, premature delivery, uterine malformation, menstrual abnormalities and low fertility. The "DES sons" show testicular dysgenesis syndrome, which is characterized by hypospadias, cryptorchidism and low semen quality. This entity is also associated to the fetal exposure to anti-androgens as flutamide. The effects on the reproductive axis depend on the stage of development and the window of exposure, as well as the dose and the compound. The wide distribution of EDC into the environment affects both human health and ecosystems in general, the study of their mechanisms of action is extremely important currently.


Diversas perturbaciones durante el desarrollo fetal y posnatal desencadenan adaptaciones endocrinas que modifican permanentemente el metabolismo, incrementando la susceptibilidad para el desarrollo de enfermedades, proceso conocido como "programación durante el desarrollo". Los compuestos disruptores endocrinos (CDE) se encuentran en el medio ambiente y presentan actividad estrogénica, antiestrogénica o antiandrogénica; son altamente lipofílicos y se almacenan por periodos prolongados en el tejido adiposo. La exposición materna a CDE durante el embarazo y la lactancia permite su paso al producto a través de la placenta y la leche materna. Estudios epidemiológicos y experimentales han demostrado alteraciones en el eje reproductivo como consecuencia de la exposición intrauterina y/o neonatal a CDE. El compuesto mejor documentado es el dietilestilbestrol (DES), este estrógeno sintético fue administrado a mujeres embarazadas durante los 50s y 60s y retirado del mercado por su implicación en anormalidades urogenitales de los bebés expuestos in útero. Las denominadas "hijas del DES" son mujeres con alta incidencia de hipoplasia vaginal, malformaciones uterinas, irregularidades menstruales, baja fertilidad y alta prevalencia de aborto espontáneo y parto prematuro. Por su parte, "los hijos del DES" presentan una entidad clínica conocida como síndrome de disgenesia testicular caracterizado por hipospadias, criptorquidia y baja calidad del semen. Este síndrome también se asocia a la exposición fetal a compuestos antiandrogénicos como la ñutamida. Los efectos en el eje reproductivo dependen del estadio de desarrollo y del tiempo de exposición, así como de la dosis y el compuesto del que se trate. La extensa presencia de CDE en el ambiente afecta la salud humana e impacta al ecosistema en general por lo cual es de suma importancia el estudio de los mecanismos involucrados en su acción.


Subject(s)
Adult , Animals , Female , Humans , Male , Pregnancy , Rats , Abnormalities, Drug-Induced/etiology , Endocrine Disruptors/adverse effects , Genitalia/drug effects , Prenatal Exposure Delayed Effects , Abnormalities, Drug-Induced/epidemiology , Androgen Antagonists/adverse effects , Androgen Antagonists/pharmacology , Breast/embryology , Diethylstilbestrol/adverse effects , Diethylstilbestrol/pharmacology , Diethylstilbestrol/therapeutic use , Dioxins/adverse effects , Embryonic Development/drug effects , Endocrine Disruptors/pharmacology , Estrogen Antagonists/adverse effects , Estrogen Antagonists/pharmacology , Estrogens/agonists , Feminization/chemically induced , Feminization/embryology , Genitalia/abnormalities , Genitalia/embryology , Hypothalamus/abnormalities , Hypothalamus/drug effects , Hypothalamus/embryology , Mammary Glands, Animal/embryology , Milk, Human/chemistry , Phthalic Acids/adverse effects , Phytoestrogens/adverse effects , Phytoestrogens/pharmacology , Phytoestrogens/therapeutic use , Virilism/chemically induced , Virilism/embryology
SELECTION OF CITATIONS
SEARCH DETAIL